Tag: luminalB
Articles
- African-American breast cancer patients can improve their breast cancer outcomes
- Breast cancer types
- ER+/PR- breast cancer
- ER-/PR+ breast cancer
News
- Age and breast cancer subtype influence prognosis after lumpectomy
- Although similar, ER+/PR- breast cancer is more aggressive than ER+/PR+
- Animal model of ER+/PR+ breast cancer shows that estrogen fuels recurrence
- Aspirin use is associated with reduced risk of breast cancer, but ibuprofen may increase it
- Breast cancer subtype influences prognosis after neoadjuvant chemotherapy
- Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
- Different breast cancer subtypes are prone to metastasize to different sites in the body
- Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
- Luminal breast cancer prognosis can vary based on other tumor characteristics
- Metformin reduces cancer proliferation, but only in those with insulin resistance
- Oral contraceptive use at young age increases risk of triple negative breast cancer
Studies
- A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative
- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
- Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers
- Brain metastases free survival differs between breast cancer subtypes
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
- Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy
- Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
- Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy
- Differential response from neoadjuvant chemotherapy across breast cancer subtypes
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- ER+ PR- breast cancer defines a unique subtype of breast cancer that is driven by growth factor signaling and may be more likely to respond to EGFR targeted therapies
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
- Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
- Invasive lobular breast cancer: subtypes and outcome
- Lipophilic statin use and risk of breast cancer subtypes
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- Luminal breast cancer metastasis is dependent on estrogen signaling
- Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer
- Molecular subtyping of male breast cancer by immunohistochemistry
- Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype
- Outcome of special types of luminal breast cancer
- Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
- Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in northeast china
- Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
- Relationship of body mass index to the intrinsic subtypes of breast cancer
- Subtypes, race and long-term survival in the Carolina Breast Cancer Study
- Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study
- Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer